Pharma BD Deal Intelligence

Pfizer Inc. / Warner-Lambert Company

2000 · Acquisition/Merger · $90.0B · Complete

Announcement Sentiment

Skeptical

Outcome Score

Worked — the deal delivered on its rationale.

Pfizer acquired Warner-Lambert in a $90 billion all-stock merger, ending a hostile takeover battle that began in November 1999. The deal gave Pfizer full ownership of Lipitor (atorvastatin), then the world's best-selling drug, along with Warner-Lambert's Parke-Davis pharmaceutical and consumer health portfolios.

Key facts

Announced Feb 07, 2000
Closed Jun 19, 2000
Deal value $90.0B
Deal type Acquisition/Merger
Therapeutic area Cardiovascular, Infectious Disease, Metabolic, Neurology
Indications Hypercholesterolemia, Cardiovascular Disease, HIV/AIDS, Epilepsy
Key assets Lipitor (atorvastatin), Norvasc (amlodipine), Celebrex (celecoxib), Viagra (sildenafil), Zoloft (sertraline), Zithromax (azithromycin), Diflucan (fluconazole), Neurontin (gabapentin), Viracept (nelfinavir), Listerine
Mechanism HMG-CoA reductase inhibitor (statin)

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals